Subscribe
shutterstock_1086968018_jarretera-2
Jarretera / Shutterstock.com
17 June 2019Americas

FDA selects Merck, IBM, KPMG and Walmart for blockchain pilot

The US Food and Drug Administration (FDA) has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More on this story

Americas
Boehringer Ingelheim teams up with IBM to explore blockchain
13 February 2019   The Canadian units of IBM and pharmaceutical company Boehringer Ingelheim have united to explore the use of blockchain technology in clinical trials.
Americas
IBM patent targets blockchain in open scientific research
14 November 2018   Technology company IBM is seeking to patent the use of blockchain in open scientific research, including experiments, data collection, and analysis.
Americas
3M drops IBM healthcare software suit
20 February 2020   US conglomerate 3M has dropped its copyright infringement claim against technology company IBM less than one month after filing suit.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York